Every material Form 8-K SERA PROGNOSTICS, INC. has filed with the SEC since August 12, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Sera Prognostics reported third-quarter 2026 results for the period ended September 30, 2026. Test revenue rose 163% year over year to $42,000, but the net loss widened to $8.1 million, and the company said revenue was held back by lower average selling prices from a higher mix of low or non-reimbursed tests.
Cash, cash equivalents and marketable securities were $72.8 million at quarter end, with Q3 operating cash burn of $7.3 million.
Florida Medicaid added the PreTRM test to its covered list and fee schedule, bringing covered Medicaid lives to about 7 million, following Illinois, which set a $525 fee schedule rate.
Sera Prognostics appointed Scott Gleason as Chief Financial Officer and Treasurer effective August 31, 2026, replacing Austin Aerts, who steps down from the role on the same date. Aerts will move to an advisory role and a consulting agreement, and Gleason receives a $400,000 base salary and a $500,000 initial equity award, subject to Board approval.
Scott Gleason, 47, becomes CFO and Treasurer effective August 31, 2026, after the board appointment on August 14, 2026.
Gleason's employment agreement sets a $400,000 base salary and a target bonus of 40% of base salary, pro-rated for 2026.
Austin Aerts receives nine months of base salary continuation totaling $354,921.75 and a consulting role at $375 per hour, for a term of twelve months from September 8, 2026.
Gleason's agreement provides twelve months of base salary and target bonus in a lump sum, plus full equity acceleration, if terminated without Cause within three months before or twelve months after a Change in Control.
Sera Prognostics reported second-quarter 2026 results on August 12, 2026, in a press release furnished as Exhibit 99.1. Revenue rose to $30,000 from $17,000, but operating expenses increased to $10.0 million and the net loss widened to $9.1 million from $8.0 million. The company said it ended the quarter with about $80.3 million in cash, cash equivalents and available-for-sale securities.
Q2 2026 revenue was $30,000, up from $17,000 in Q2 2025.
Net loss was $9.1 million, or $0.18 per share, versus $8.0 million, or $0.16 per share, a year earlier.
Total operating expenses were $10.0 million, compared with $9.3 million in the prior-year quarter.
Cash, cash equivalents and available-for-sale securities were about $80.3 million, which the company says will fund operations through 2029.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every SERA PROGNOSTICS, INC. filing is on SEC EDGAR ↗. 8-K briefs of other companies →